![PDF) Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of PDF) Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of](https://i1.rgstatic.net/publication/352086677_Efficacy_and_safety_of_early_target-controlled_plasma_volume_replacement_with_a_balanced_gelatine_solution_versus_a_balanced_electrolyte_solution_in_patients_with_severe_sepsisseptic_shock_study_proto/links/60b8666492851cb13d6fc80c/largepreview.png)
PDF) Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of
![PDF) Evaluation of a commercial multi-dimensional echocardiography technique for ventricular volumetry in small animals PDF) Evaluation of a commercial multi-dimensional echocardiography technique for ventricular volumetry in small animals](https://www.researchgate.net/publication/326158531/figure/fig4/AS:647038022725633@1531277294906/figure-fig4_Q320.jpg)
PDF) Evaluation of a commercial multi-dimensional echocardiography technique for ventricular volumetry in small animals
![PDF) A morpho-functional study using PEP/LVET ratio and global longitudinal strain in patients with dilated cardiomyopathy PDF) A morpho-functional study using PEP/LVET ratio and global longitudinal strain in patients with dilated cardiomyopathy](https://www.researchgate.net/profile/Dragos-Alexandru-2/publication/325996927/figure/fig1/AS:776660571934721@1562181718346/Transthoracic-echocardiography-in-apical-5-chamber-view-Pulsed-wave-Doppler_Q320.jpg)
PDF) A morpho-functional study using PEP/LVET ratio and global longitudinal strain in patients with dilated cardiomyopathy
![PDF) Preclinical dosimetric studies of 177 Lu‐scFvD2B and comparison with 177 Lu‐PSMA‐617 and 177 Lu‐iPSMA endoradiotherapeutic agents PDF) Preclinical dosimetric studies of 177 Lu‐scFvD2B and comparison with 177 Lu‐PSMA‐617 and 177 Lu‐iPSMA endoradiotherapeutic agents](https://i1.rgstatic.net/publication/351441346_Preclinical_dosimetric_studies_of_177_Lu-scFvD2B_and_comparison_with_177_Lu-PSMA-617_and_177_Lu-iPSMA_endoradiotherapeutic_agents/links/60bf74b3a6fdcc5128128de2/largepreview.png)
PDF) Preclinical dosimetric studies of 177 Lu‐scFvD2B and comparison with 177 Lu‐PSMA‐617 and 177 Lu‐iPSMA endoradiotherapeutic agents
![EP0125023A1 - Rekombinante Immunoglobulin-Präparate, Verfahren zu ihrer Herstellung, DNA-Sequenzen, Expressionsvektoren und rekombinante Wirkzellen hierfür - Google Patents EP0125023A1 - Rekombinante Immunoglobulin-Präparate, Verfahren zu ihrer Herstellung, DNA-Sequenzen, Expressionsvektoren und rekombinante Wirkzellen hierfür - Google Patents](https://patentimages.storage.googleapis.com/ec/0e/a1/33e6fdff92be14/imgf0011.png)